Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × UNKNOWN × Sarcoma × Clear all

Phase

Phase 2 2 Phase NA 1

Status

Sponsor Class

OTHER 619 NIH 160 INDUSTRY 156 NETWORK 90 OTHER_GOV 10 UNKNOWN 2 INDIV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 38 Breast 28 Thoracic 13 Head & Neck 10 Lymphoid 7 Gynecologic 3 CNS 3 Sarcoma 2 Genitourinary 2 Other solid neoplasm 1 Other neoplasm 1 NET 1 Endocrine 1

Conditions

Interventions

endostar protein 1 camrelizumab 1 apatinib 1 Gemcitabine 1 Endostatins 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447274 2020-06-25

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

ChineseAMS

Phase 2 Unknown

Sarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡